Pulmonary arterial hypertension: updates and perspective with newer therapies.

Intern Med J

Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia.

Published: December 2024

Pulmonary arterial hypertension (PAH) is a rare condition for which a remarkable change has been witnessed in the epidemiology, assessment and treatment landscape over the last three decades. Well-established registries from the Western world have not only highlighted the shift in the epidemiology to an older, more comorbid cohort but have also identified markers of prognosis that have been validated as part of risk stratification scores in multiple cohorts. The emphasis on early identification through a systematic assessment pathway and the option of upfront combination therapy with serial risk stratification assessment has laid the foundation for the standard of care and improved prognosis. This review provides an update on the assessment and newer therapies for PAH.

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.16515DOI Listing

Publication Analysis

Top Keywords

pulmonary arterial
8
arterial hypertension
8
newer therapies
8
risk stratification
8
hypertension updates
4
updates perspective
4
perspective newer
4
therapies pulmonary
4
hypertension pah
4
pah rare
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!